Stay updated on Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Sign up to get notified when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.

Latest updates to the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.2. This marks a new revision of the page content on ClinicalTrials.gov.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page now displays Revision: v3.6.2 in the footer, replacing the previous v3.6.0, indicating a version update to the page template or content.SummaryDifference0.0%

- Check32 days agoChange DetectedA recruitment notice 'No longer looking for participants' has been added to the study page. The page also introduces new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment label from the previous Intervention / Treatment.SummaryDifference0.4%

- Check39 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, signaling a minor patch to the page template. This change does not alter study information or visible content.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4. This indicates a small, non-content-changing update to the document metadata.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded the NIH grant number R01CA219960 and two new study-record dates (2026-04-20 and 2026-05-04) to the study record, and removed older identifiers (NCI-2017-00113 and MC1685) as well as earlier dates (2025-05-15 and 2025-05-16). These edits update funding attribution and internal registry references used for record-keeping.SummaryDifference0.3%

Stay in the know with updates to Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.